Literature DB >> 7746622

Prevalence of posterior vitreous detachment in retinitis pigmentosa.

T Hikichi1, J Akiba, C L Trempe.   

Abstract

To investigate the prevalene of posterior vitreous detachment (PVD) and PVD with collapse in relation to age in eyes with retinitis pigmentosa (RP), we retrospectively studied the vitreous condition in 218 eyes of 109 patients with RP. Two hundred thirty healthy eyes of 115 subjects served as controls. The prevalence of both PVD and PVD with collapse, respectively, in the first through the sixth decades of life, and the second through the seventh decades was significantly higher in the RP eyes than in the controls (P < .01). Our findings demonstrated the early onset and progression of PVD with age in the eyes with RP as compared with the control eyes.

Entities:  

Mesh:

Year:  1995        PMID: 7746622

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  4 in total

1.  Vitreo-macular interface disorders in retinitis pigmentosa.

Authors:  Serena Fragiotta; Tommaso Rossi; Carmela Carnevale; Alessandro Cutini; Stefano Tricarico; Lorenzo Casillo; Gianluca Scuderi; Enzo Maria Vingolo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-19       Impact factor: 3.117

2.  Prevalence and risk factors of posterior vitreous detachment in a Chinese adult population: the Handan eye study.

Authors:  Zhijun Shen; Xinrong Duan; Fenghua Wang; Ningli Wang; Yi Peng; David T L Liu; Xiaoyan Peng; Sizhen Li; Yuanbo Liang
Journal:  BMC Ophthalmol       Date:  2013-07-16       Impact factor: 2.209

3.  Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study.

Authors:  Ayse Oner; Z Burcin Gonen; Neslihan Sinim; Mustafa Cetin; Yusuf Ozkul
Journal:  Stem Cell Res Ther       Date:  2016-12-01       Impact factor: 6.832

4.  Retinal detachment in retinitis pigmentosa.

Authors:  Weng Onn Chan; Nicholas Brennan; Andrew R Webster; Michel Michaelides; Mahiul M K Muqit
Journal:  BMJ Open Ophthalmol       Date:  2020-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.